Pacer Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,806
| Closed | -$29K | – | 1443 |
|
|
2021
Q1 | $29K | Buy |
3,806
+1,000
| +36% | +$7.62K | ﹤0.01% | 1481 |
|
|
2020
Q4 | $18K | Buy |
2,806
+366
| +15% | +$2.35K | ﹤0.01% | 1487 |
|
|
2020
Q3 | $16K | Buy |
+2,440
| New | +$16K | ﹤0.01% | 1362 |
|
|
2018
Q4 | – | Sell |
-4,431
| Closed | -$82K | – | 659 |
|
|
2018
Q3 | $82K | Buy |
+4,431
| New | +$82K | ﹤0.01% | 1111 |
|
|
2018
Q1 | – | Sell |
-525
| Closed | -$11K | – | 1057 |
|
|
2017
Q4 | $11K | Buy |
+525
| New | +$11K | ﹤0.01% | 1138 |
|